Guidance document : post-notice of compliance (NOC) changes : safety and efficacy document (for pharmaceutical, biologic and radiopharmaceutical drugs for human use only).: H164-281/1-2019E-PDF

Permanent link to this Catalogue record:
publications.gc.ca/pub?id=9.880801&sl=0

Publication information
Department/Agency Canada. Health Canada, issuing body.
Title Guidance document : post-notice of compliance (NOC) changes : safety and efficacy document (for pharmaceutical, biologic and radiopharmaceutical drugs for human use only).
Variant title Post-notice of compliance (NOC) changes : safety and efficacy document (for pharmaceutical, biologic and radiopharmaceutical drugs for human use only)
Publication type Monograph
Language [English]
Other language editions [French]
Format Electronic
Electronic document
Note(s) Issued also in French under title: Ligne directrice : changements survenus après l'avis de conformité (AC) : document sur l'innocuité et l'efficacité (pour les produits biologiques, pharmaceutiques et radiopharmaceutiques à usage humain seulement).
"Publication date: November 2019."
"Pub.: 190400."
Issued also in HTML format.
Publishing information Ottawa, ON : Health Canada = Santé Canada, 2019.
©2020
Description 1 online resource (24 pages)
ISBN 9780660329550
Catalogue number
  • H164-281/1-2019E-PDF
Subject terms Drugs -- Labeling -- Canada.
Drug approval -- Canada.
Request alternate formats
To request an alternate format of a publication, complete the Government of Canada Publications email form. Use the form’s “question or comment” field to specify the requested publication.
Report a problem or mistake on this page
Date modified: